European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Pregabalin Viatris (previously Pregabalin Mylan), pregabalin, Date of authorisation: 24/06/2015, Revision: 24, Status: Authorised

Submitted by Anonymous (not verified) on 8 May 2026 - 10:54

Human medicines European public assessment report (EPAR): Pregabalin Viatris (previously Pregabalin Mylan), pregabalin, Date of authorisation: 24/06/2015, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Pomalidomide Viatris, pomalidomide, Date of authorisation: 16/02/2024, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 8 May 2026 - 10:50

Human medicines European public assessment report (EPAR): Pomalidomide Viatris, pomalidomide, Date of authorisation: 16/02/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris, emtricitabine,rilpivirine,tenofovir alafenamide, Date of authorisation: 19/08/2025, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 8 May 2026 - 10:44

Human medicines European public assessment report (EPAR): Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris, emtricitabine,rilpivirine,tenofovir alafenamide, Date of authorisation: 19/08/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 20, Status: Authorised

Submitted by Anonymous (not verified) on 8 May 2026 - 10:32

Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 20, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness